Rxo (RXO) Shares Outstanding (Diluted Average) (2021 - 2026)

Rxo (RXO) has reported Shares Outstanding (Diluted Average) for 6 consecutive years, with $169.1 million the latest figure, recorded in Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $169.1 million, up 0.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $169.1 million (up 0.64% YoY), and the FY2025 annual result was $168.5 million, up 26.27% from the prior year.
• Shares Outstanding (Diluted Average) was $169.1 million for Q1 2026 at Rxo, roughly flat from $168.5 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $169.1 million in Q1 2026 and troughed at $115.0 million in Q3 2022.
• Average Shares Outstanding (Diluted Average) over 5 years is $134.2 million, with a median of $119.5 million recorded in 2023.
• Year-over-year, Shares Outstanding (Diluted Average) slipped 1.8% in 2024 and jumped 43.34% in 2025.
• Over 5 years, Shares Outstanding (Diluted Average) stood at $115.8 million in 2022, then increased by 3.17% to $119.5 million in 2023, then climbed by 11.68% to $133.4 million in 2024, then advanced by 26.27% to $168.5 million in 2025, then increased by 0.38% to $169.1 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Diluted Average) figures were $169.1 million in Q1 2026, $168.5 million in Q4 2025, and $168.6 million in Q3 2025.